CELLDEX THERAPEUTICS INC (CLDX)
NASDAQ • Healthcare
$41.79
-$0.13 (-0.3%)
Market open
Last close at August 18, 2026 at 20:00 UTC
Fundamentals Charts
About CELLDEX THERAPEUTICS INC
Name
CELLDEX THERAPEUTICS INC
CEO
Anthony S. Marucci
Website
Industry
Healthcare
Year Founded
1983
Employees
198
Celldex Therapeutics, Inc. develops antibody-based treatments as a biotechnology company in the healthcare sector and trades on the NASDAQ under CLDX. Founded in 1983, Celldex is a small-cap drug developer focused on monoclonal and bispecific antibodies aimed at inflammatory diseases and cancers.
Fundamentals & Financials
Revenue (TTM)
$112K
Net Income (TTM)
-$300.5M
EPS (TTM)
-$4.36
ROA (TTM)
-38.42%
Current Ratio
11.82
TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.
Income Statement
Balance Sheet
Financial Highlights
Dividends History
Split History
Earnings Calendar
Stay Ahead of the Market
Get premium market insights delivered directly to your inbox.
Quote Summary
Previous CloseDay Range$41.79$41.03 - $42.36
52 Week RangeAvg. Volume$20.37 - $45.14995.8K
Market Cap$2.7B
Peers & Related Assets
SYRESPYRE THERAPEUTICS INC
$107.82+3.1%
IMNMIMMUNOME INC
$27.56+0.6%
NUVBNUVATION BIO INC CLASS A
$6.96+7.4%
VERAVERA THERAPEUTICS INC CLASS A
$32.28+2.1%
BHVNBIOHAVEN LTD
$13.57-6.2%
ABCLAbCellera Biologics Inc.
QUREuniQure N.V.
HRMYHARMONY BIOSCIENCES HLDG INC
JANXJANUX THERAPEUTICS INC
SIONSIONNA THERAPEUTICS INC